Healthcare | September 23, 2022
KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
This will give a boost to cost-effective, quality medicines and contribute towards reduction in out of pocket expenditure on healthcare for the citizens
Celgene agreed to provide Dr. Reddy's with a license to sell volume-limited amounts of generic lenalidomide capsules in the U.S.
Lupin’s subsidiary in Philippines, Multicare Pharmaceuticals, will file for marketing approval and be responsible for distribution and commercialization of the biosimilars once approved.
NCDC branches in States/UTs will provide a boost to Public Health Infrastructurewith prompt surveillance, rapid detection and timely monitoring of diseases enabling Early Interventions
This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
The existing hospital premises has the scope to further scale up the bed capacity as and when required in the future with minimal Capex.
It is high time that India assumed a leadership role in healthcare.
Subscribe To Our Newsletter & Stay Updated
